Lumen Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Lumen Bioscience's estimated annual revenue is currently $13.9M per year.
- Lumen Bioscience's estimated revenue per employee is $155,000
- Lumen Bioscience's total funding is $47.5M.
Employee Data
- Lumen Bioscience has 90 Employees.
- Lumen Bioscience grew their employee count by 3% last year.
Lumen Bioscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder | Reveal Email/Phone |
2 | CEO & Founder | Reveal Email/Phone |
3 | CFO --> Advisor | Reveal Email/Phone |
4 | EVP, Production and Development | Reveal Email/Phone |
5 | VP Finance, Controller | Reveal Email/Phone |
6 | Head Lab Operations | Reveal Email/Phone |
7 | VP, Head Legal | Reveal Email/Phone |
8 | VP, Clinical | Reveal Email/Phone |
9 | VP Business Development | Reveal Email/Phone |
10 | VP, Human Resources | Reveal Email/Phone |
Lumen Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14M | 90 | 3% | $47.5M | N/A |
What Is Lumen Bioscience?
Lumen Bioscience develops oral antibody therapeutics.
keywords:N/A
$47.5M
Total Funding
90
Number of Employees
$13.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lumen Bioscience News
Seattle's Lumen Bioscience completed a phase 1 study of its capsules for C. difficile infections, produced with green algae.
Lumen Bioscience Announces Clinical Advancement of LMN-201 for C. difficile Infection. Published: Apr 18, 2022. FDA clearance of investigational new drug...
Lumen Bioscience: Spirulina-based platform enables rapid, low-cost development of oral biologics ... Spirulina has been converted into a...
SEATTLE, Sept. 1, 2021 /PRNewswire/ -- Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the start of a Phase 1 trial of LMN-Cdiff01, an orally delivered investigational biologic for treatment and prevention of ...
Caitlin Gamble, head of informatics at Lumen Bioscience. (Lumen Photo) Can machine learning help spur the production of algae-based biologics? That’s the question new research from Seattle biotech startup Lumen Bioscience and Google aims to answer. The companies announced a collaboration on We ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 90 | 7% | N/A |
#2 | $22.1M | 90 | 8% | N/A |
#3 | $24.3M | 90 | 3% | N/A |
#4 | $13.5M | 90 | -6% | N/A |
#5 | $26.1M | 90 | 5% | N/A |